To assist companies as they plan for the year ahead, US-China Business Council staff compiled short summaries of the recent laws and regulations in China and those expected to be acted on in 2018. The first of this series of summaries focuses on agriculture, healthcare and intellectual property rights. Sectors covered in upcoming editions will cover information technology, financial services, energy and environment and automotive industry issues.
Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.
The Chinese healthcare sector, which accounted for 6 percent of the country’s GDP in 2016, is expected to capture a 10 percent share in the coming years.